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Macrophages contribute to HIV-1 pathogenesis by
forming a viral reservoir and mediating neurological
disorders. Cell-free HIV-1 infection of macrophages
is inefficient, in part due to low plasma membrane
expression of viral entry receptors. We find that mac-
rophages selectively capture and engulf HIV-1-in-
fected CD4+ T cells leading to efficient macrophage
infection. Infected T cells, both healthy and dead
or dying, were taken up through viral envelope glyco-
protein-receptor-independent interactions, implying
a mechanism distinct from conventional viro-
logical synapse formation. Macrophages infected
by this cell-to-cell route were highly permissive for
both CCR5-using macrophage-tropic and otherwise
weakly macrophage-tropic transmitted/founder vi-
ruses but restrictive for nonmacrophage-tropic
CXCR4-using virus. These results have implications
for establishment of the macrophage reservoir and
HIV-1 dissemination in vivo.
INTRODUCTION
Macrophages are scavengers that phagocytose dead and dying
cells during normal tissue homeostasis, and detect and eliminate
infected cells in their role as innate immune sentinels (Devitt and
Marshall, 2011; Poon et al., 2010). In immunodeficiency virus-in-
fected hosts, macrophages may comprise up to 10% of infected
cells (Zhang et al., 1999), survive for extended periods as a viral
reservoir (Gorry et al., 2014), and drive infection-related neuro-
logical disorders (Burdo et al., 2013). Tropism of HIV-1 for mac-Cell Host &rophages is determined both by receptor (CD4) and coreceptor
(CCR5 and CXCR4) expression (R5 and X4 viruses, respectively)
and by additional less well-defined factors (Duncan and Satten-
tau, 2011). Viruses transmitted between individuals, termed
transmitted/founder (T/F) viruses, areminimally tropic for macro-
phages (Ochsenbauer et al., 2012; Salazar-Gonzalez et al.,
2009), implying that macrophage infection occurs at a late stage
after viral transmissionwhen the virus has adapted to infect mac-
rophages more efficiently.
Macrophage infection by cell-free HIV-1 is rate limited by fluid-
phase uptake (Carter et al., 2011; Mare´chal et al., 2001) and low
plasmamembrane expression levels of viral entry receptors (Lee
et al., 1999). A mode of retroviral infection of CD4+ T cells that is
more efficient than cell-free spread is cell-to-cell spread (Dale
et al., 2013; Sattentau, 2008), exemplified by virological synap-
ses (VSs) and associated structures that drive efficient high-mul-
tiplicity infection in vitro (Dale et al., 2013; Sattentau, 2008) and
may dominate viral dissemination in vivo (Murooka et al., 2012;
Sewald et al., 2012). Infected macrophages transfer high-multi-
plicity HIV-1 infection to CD4+ T cells, promoting reduced viral
sensitivity to reverse transcriptase inhibitors and some neutral-
izing antibodies (Duncan et al., 2013; Duncan et al., 2014; Gous-
set et al., 2008; Groot et al., 2008). However, the principal mech-
anism by which HIV-1 infects macrophages is unclear, and the
ability of HIV-1-infected T cells to transmit virus to macrophages
has not been studied. Since CD4+ T cells are proposed to be the
major cell type infected by immunodeficiency viruses at trans-
mission and throughout infection (Li et al., 2009; Zhang et al.,
1999), we investigated interactions between HIV-1-infected
T cells and macrophages to determine whether virus might
transfer directly between them. We show that primary mono-
cyte-derived macrophages (MDMs) selectively capture autolo-
gous primary HIV-1-infected CD4+ T cells, leading to infection
of MDMs that is of greater magnitude than the corresponding
cell-free virus infection, particularly for T/F viruses.Microbe 16, 711–721, December 10, 2014 ª2014 The Authors 711
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Figure 1. Macrophages Capture and Engulf HIV-1-Infected T Cells
(A) Time-lapse sequence of HIV-1-NL4.3-GFP-infected Jurkats mixed with MDM. Infected T cells are labeled 1, 2, and 3 in the engulfment order. Scale bar 10 mm.
Time shown as hh:mm:ss. See Movies S1, S2, and S3.
(B) Experimental strategy for isolation, infection, coculture, and analysis of primary donor cells.
(C) ImageStream images of pre-coculture primary HIV-1+ CD4+ T cells selected for focus, size, and aspect ratio labeled for the phenotypes analyzed: CD3 (T
cells, blue), Gag (green), Caspase3 (early apoptosis, red), or live/dead (LD, late apoptosis/necrosis, orange), and all channels merged with and without
brightfield (BF).
(D) ImageStream images of MDMs associated with T cells selected for focus, MDMs based on size and aspect ratio, then CD3+ labeling from 5 3 104 total
acquired events showing single engulfed T cells labeled for the different phenotypes analyzed.
(legend continued on next page)
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MDM Selectively Capture HIV-1-Infected Healthy and
Dying T Cells
To investigate whether HIV-1-infected T cells might interact with
macrophages, we cocultured MDM with CCR5-expressing
Jurkat-Tat-CCR5 T cells (Jurkats) or primary CD4+ T cells in-
fected with fluorescent X4 (HIV-1NL4.3-GFP
+) or R5 T/F virus
(HIV-1CH077mCherry
+) and live-cell imaged over 2 hr. Figure 1A
shows stills from Movie S1 (available online), in which a MDM
sequentially engulfs three HIV-1NL4.3/GFP
+ Jurkats. Similarly, an
MDM engulfs two HIV-1CH077/mCherry
+ Jurkats (Movie S2) or
an HIV-1CH077/mCherry
+ primary autologous CD4+ T cell (Movie
S3). These results suggest that MDM capture is selective for
HIV-1+ T cells but independent of viral tropism. Since MDMs ap-
peared to ignore apparently healthy, uninfected T cells, we hy-
pothesized that MDM might selectively engulf HIV-1+ T cells
via direct recognition of cell surface viral antigen and/or indirectly
through recognition of T cell death, since HIV-1 infection induces
T cell death by apoptosis and other mechanisms (Cooper et al.,
2013; Doitsh et al., 2014) and macrophages avidly take up dead
and dying cells (Devitt and Marshall, 2011; Poon et al., 2010).
We tested this hypothesis using multispectral flow cytometry
(ImageStream) quantitation of MDM uptake of HIV-1+ and/or
dead/dying T cells. An advantage of this technique over conven-
tional flow cytometry is that images can be quantified for capture
and internalization of T cells rather than reporting nonspecific
cell aggregation or engulfment of cell debris by MDMs. Autolo-
gous primary CD4+ T cells were isolated, infected with wild-
type (WT) R5 HIV-1BaL, and processed for imaging as described
in Figure 1B. T cells were labeled prior to coculture with
MDMs for markers of apoptosis (phosphatidylserine [PS]) or
late apoptosis/necrosis (live/dead label [LD]) (Figures 1C and
S1A–S1H), and within MDM after coculture, washing, lifting, fix-
ation, and permeabilization for CD3, Gag, and active Caspase3
(Figures 1D and S1I –S1N). Selective MDM uptake of different
T cell subsets was quantified by expressing the proportion of
each subset in the T cell culture prior to uptake, and within the
MDM population subsequent to uptake, as an uptake index (Fig-
ures S1I–S1N). An index of <1 indicates T cells are selectively
ignored, whereas an index of >1 means T cells are selectively
captured from the starting T cell pool. Uninfected (Gag) healthy
(Caspase3/PS/LD) T cells were selectively ignored byMDMs
compared to either infected/healthy (p < 0.01) or uninfected/
dead/dying (p < 0.05) captured T cells (10-fold increased cap-
ture over uninfected/ healthy). Strikingly, infected/dead/dying
T cells were highly significantly captured by MDMs compared
to uninfected/healthy (50-fold over p < 0.001) and at a signifi-
cantly higher frequency than either infected/healthy T cells (p <
0.01) or uninfected/dead/dying cells (p < 0.05) (Figure 1E). These
data demonstrate that cell death and HIV-1 infection indepen-
dently promote T cell capture by MDM, but combined they
mediate a strong uptake signal.(E) Summary of data quantified from 103 images such as those in (C) and (D) c
independent donors, three independent experiments). Percentages of MDM con
based upon the frequency of each T cell subset prior toMDM uptake relative to the
CD3+/Gag+/dead/dying) combine independent experiments reporting markers
Kruskal-Wallis one-way ANOVA with Dunn’s multiple comparison post hoc test.
Cell Host &Interactions Implicated in MDM Capture of
HIV-1-Infected T Cells
To interrogate short-term interactions mediating HIV-1+ T cell
capture by MDM, we quantified T cell uptake using qPCR of
MDM-associated viral (v)DNA (Figure 2A) or luciferase content
using the luciferase reporter HIV-1 infectious molecular clone
(IMC) HIV-1BaL-Luc (Ochsenbauer et al., 2012). HIV-1
+ T cells
were cocultured with MDM for the times indicated, stringently
washed free of unengulfed T cells, and immediately lysed and
assayed. We compared HIV-1+ T cell uptake with cell-free virus
using supernatant derived from the same HIV-1+ T cells immedi-
ately prior to coculture withMDMs or across 3 mm transwells that
prevent T cell transfer but allow free diffusion of virus (Figures
S2A–S2C) (Martin et al., 2010). vDNA copy number was normal-
ized to b-globin to account for variability in MDM number, and
the signal was further normalized to the 1 hr time point to
compensate for interdonor variability. We detected increasing
T-cell-associated, but not cell-free, HIV-1 signals in MDMs
over 6 hr (Figure 2A), consistent with cumulative T cell capture
by MDM. To investigate engulfment mechanisms, we blocked
actin remodeling, inhibiting cytoskeleton-dependent processes
including phagocytosis, or macropinocytosis, using nontoxic or
weakly toxic but functional concentrations (Figures S2D–S2F)
of jasplakinolide or amiloride (EIPA, Carter et al., 2011), respec-
tively. Jasplakinolide significantly inhibited (p < 0.01) HIV-1+
T cell uptake, whereas EIPA did not (Figure 2B), suggesting
phagocytosis, rather than macropinocytosis, as a potential up-
take mechanism. To further probe uptake interactions we tested
inhibitors of HIV-1 envelope glycoprotein (Env)-receptor and cell
death receptor engagement. None of the Env-receptor inhibitors
(Figures 2B and S3A–S3C) or published inhibitors of interactions
driving phagocytosis of dead/dying cells (Figure S4) reproduc-
ibly and significantly blocked HIV-1+ T cell uptake. We further
tested the requirement for Env-receptor interactions by assaying
uptake of CD4+ T cells infected with WT or Env-deficient HIV-1.
Both populations were equivalently captured (Figures 2C, 2D,
S3D, and S3E), confirming that HIV-1+ T cell-MDM recognition
is Env-receptor independent and therefore not mediated via
conventional VS signals (Jolly et al., 2004; Sattentau, 2008).
Capture of HIV-1-Infected T Cells Drives MDM Infection
Potential outcomes of HIV-1+ T cell uptake by MDM include
phagolysosomal elimination without MDM infection or viral
spread from T cells to infect MDM. To interrogate this we
prepared and cocultured MDM with HIV-1+ T cells (Figure 1B),
washed and maintained cultures up to 72 hr ± AZT, and
measured vDNA content. The signal rose by >10-fold from
baseline without AZT demonstrating active HIV-1 replication,
whereas with AZT it decreased by 3-fold, implying vDNA
degradation (Figure 3A). We compared infection kinetics of
MDM directly exposed to HIV-1+ T cells or across transwells
and assayed released viral p24 Gag representing productive
infection. Direct coculture of HIV-1+ T cells with MDM for 3 hrounted for engulfed T cell phenotype (each circle represents one donor, nine
taining different subsets of T cells were calculated and expressed as an index
frequency after uptake. The third and fourth categories (CD3+/dead/dying and
of cell death: Caspase3 and LD (red) or PS (blue). Statistical analysis using
*p < 0.05; **p < 0.01; ***p < 0.001. See Figure S1.
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Figure 2. Interactions Implicated in MDM
Capture of HIV-1-Infected T Cells
(A) Short-term MDM uptake assay of HIV-1BaL
+
primary T cells via direct contact (cell-to-cell, CTC,
red), across transwells (TW, black), or HIV-1Bal
T cell supernatants added directly to MDM (cell-
free, CF, white). Uptake was measured by qPCR
for MDM-associated pol vDNA, normalized to
b-globin copy number and to cell-cell transfer at
1 hr = 1. Bars =mean relative HIV-1 DNA copies for
five donors + SEM, each donor analyzed in tripli-
cate. **p < 0.01; ***p < 0.001 by Kruskal-Wallis
one-way ANOVA with Dunn’s multiple comparison
post hoc test comparing all to CTC T = 0.25. See
Figures S2A–S2C.
(B) Inhibition of MDM uptake of HIV-1BaL
+ primary
T cells. MDMs (Jasp, EIPA, 13B8.2, Tak779, and
T20) or HIV-1BaL
+ T cells (2G12, sCD4, and T20)
were pretreated for 1 hr with saturating con-
centrations of inhibitors, cocultured for 30 min,
washed to remove unattached T cells, DNA ex-
tracted, and qPCR for pol vDNA and b-globin
performed. Bars = mean uptake inhibition (%)
for each treatment normalized to appropriate
controls + SEM for 4 to 13 independent donors,
each analyzed in triplicate. **p < 0.01; ***p < 0.001
by one-sample t test comparing each treatment to
a hypothetical value of 0 (no inhibition) with Sidak’s multiple comparison post hoc test. See Figures S2D–S2F, S3B, and S4.
(C and D) Env is not required for HIV-1+ T cell uptake. CD4+ T cells were synchronously infected for 48 hr with HIV-1BaL or VSV-G pseudotyped HIV-1BaLDEnv and
cultured 1:1 with autologous MDM for 3 hr. MDMs were washed lifted, fixed, permeabilized, and analyzed for intracellular CD3 and Gag by flow cytometry. Bars
equal normalized mean of flow cytometry data from two independent donors each analyzed in triplicate + SEM.
(C) Percentage Gag+ CD4+ T cells (blue bars) and MDMs (black bars).
(D) Normalized uptake of Gag+MDM/Gag+ T cells (%Gag+MDM /%Gag+ T cells). Bars = normalized mean of flow cytometry data from two independent donors
each analyzed in triplicate. ns = p > 0.05, Mann-Whitney U. See Figures S3D and S3E.
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By contrast, 3 hr exposure of MDM to HIV-1+ T cells across
transwells did not result in a spreading infection, and 6 and
12 hr transwell exposure resulted in delayed Gag release with
substantially lower peak values.
Although these data imply MDM infection, a proportion of
Gag release might result from virus production by MDM-
captured HIV-1+ T cells. We therefore investigated whether
MDM became infected in the absence of residual T cells. CD4+
T cells were infected with HIV-1NL4.3-eGFP-BaL, cocultured with
MDM for 3 days to approximate a single-cycle MDM infection,
washed, and imaged.We observed5%MDMwith strong cyto-
plasmic GFP expression in the absence of detectable T cells
(Figures 3C and 3D) that was eliminated by AZT treatment,
demonstrating direct MDM infection, whereas cell-free infection
yielded an insignificant GFP+ MDM signal. To further investigate
the link between HIV-1+ T cell capture and MDM infection, we
maintained cocultures for 3 days following uptake inhibition ex-
periments and measured Gag release. Jasplakinolide, which
reduced HIV-1+ T cell uptake (Figure 2B), strongly (p < 0.01) in-
hibited T-cell-mediated MDM infection but weakly (p > 0.05)
reduced cell-free infection (Figure 3E). We tested for inhibition
of MDM infection by extended culture of MDMs exposed to
HIV-1+ T cells, in the continued presence of entry inhibitors. All
inhibitors reduced MDM infection (Figure 3F), demonstrating
that although these reagents do not prevent HIV-1+ T cell capture
by MDM (Figure 2B), they act at a subsequent step to block viral
entry into MDM. Therefore MDM infection through this route is714 Cell Host & Microbe 16, 711–721, December 10, 2014 ª2014 Thdependent on Env-receptor interactions. Further confirmation
of MDM infection by HIV-1+ T cell capture was obtained using
MDMs derived from an individual homozygous for the CCR5
D32 mutation, which are resistant to R5 HIV-1 infection (Bol
et al., 2009). These MDMs were confirmed CCR5 null compared
to cells from WT individuals (Figure S5A). Heterologous CCR5+
primary CD4+ T cells infected with HIV-1BaL-Luc were directly co-
cultured with, or exposed across transwells to, DCCR5 or WT
donorMDM for 6 hr, washed, cocultured for 3 days, and assayed
for luciferase. Figure 3G shows that theDCCR5MDMs produced
weak signals not significantly above baseline, probably reflect-
ing residual T-cell-associated HIV-1, whereas the four WT donor
MDM signals were 10-fold higher for both direct coculture and
cell-free infection, demonstrating MDM infection.
To investigate the possibility that HIV-1 transfer from T cells to
MDMs yields an abortive infection at a late stage of viral replica-
tion, we cocultured MDM with HIV-1+ T cells directly or across
transwells for 6 hr, washed, cultured for 3 days, and assayed su-
pernatant infectivity on TZM-bl cells. Significantly more infec-
tious virus (p < 0.05) was released from MDM directly exposed
to infected T cells than exposed to cell-free virus (Figure 3H).
We also added autologous CD4+ T cells ± AZT to these MDM
to act as indicators of onward cell-to-cell HIV-1 spread from
MDMs to T cells. This revealed efficient HIV-1 infection of the re-
porter T cells that was greater in magnitude from MDMs initially
cocultured with infected CD4+ T cells than infected across trans-
wells, and infection was abolished by AZT (Figure 3I). Taken
together, these data demonstrate that exposure of MDMs toe Authors
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Figure 3. MDM Are Efficiently Infected by
HIV-1+ T Cells
(A)MDM infection by capture of HIV-1+ T cells. HIV-
1BaL
+ primary T cells were cocultured with MDMs
for 3 hr, T cells washed off, and MDMs cultured ±
AZT for the times shown prior to lysis and qPCR for
HIV-1 pol product normalized to b-globin copy
number. Data represent mean relative HIV-1 vDNA
copies from four independent donors + SEM. *p <
0.05, as determined by Kruskal-Wallis one-way
ANOVA with Dunn’s multiple comparison post hoc
test, normalized to T = 0 + AZT.
(B) HIV-1BaL-infected primary CD4
+ T cells directly
cocultured with autologous MDM (CTC) or sepa-
rated by virus-permeable transwell (TW) mem-
branes for the times shown were washed, further
cultured, and supernatant Gag assayed. Results
are means of experimental quadruplicates+ SEM
from an experiment representative of three inde-
pendent experiments each with an independent
donor. See Figures S2A–S2C.
(C) HIV-1BaL-GFP
+ primary T cells were cocultured
for 6 hr with autologous MDMs; extensively
washed; and MDMs were cultured for 3 days,
fixed, permeabilized, and prepared for confocal
microscopy. Each image represents a single op-
tical x-y section, cells labeled for CD3 (red) and
nuclei (blue). Scale bars = 20 mm. Top panel, MDM
exposed to cell-free HIV-1BaL-GFP through 3 mm
transwell membranes; middle panel: MDM + AZT
prior to and during coculture with HIV-1BaL-GFP
+
T cells; bottom panel: MDMs directly cocultured
with HIV-1BaL-GFP
+ T cells.
(D) Quantification from images represented in (C).
MDMs under each condition were quantified for
GFP expression, and data was expressed as
means of + SEM of n = 500 MDMs in five randomly
selected fields from four independent donors. *p <
0.05 Kruskal-Wallis one-way ANOVA with Dunn’s
multiple comparison post hoc test.
(E) Jasplakinolide inhibits HIV-1+ T-cell-mediated,
but not cell-free, infection of MDMs. Jasplakino-
lide (Jasp, 5 mM) was added to MDMs for 1 hr prior
to washing and direct coculture with HIV-1Bal
+
T cells (CTC, red) or their supernatants (CF,
black). Infection was measured by supernatant
Gag levels 3 days post-coculture. Bars = mean
inhibition of infection (%) + SEM for four inde-
pendent donors, each in triplicate. ***p < 0.001 by
one-sample t test, comparing each condition to a
hypothetical value of 0 with Sidak’s multiple
comparison post hoc test. See Figure S2.
(F) HIV-1 entry inhibitors block MDM infection. MDMs were cocultured with autologous HIV-1BaL
+ T cells for 3 hr, washed extensively to remove unattached
T cells, and cultured with entry inhibitors for 14 days with Gag release assayed every 2 days. Bars = AUC analysis normalized to no drug controls and expressed
as inhibition of infection (%) + SEM for four donors, each in triplicate. *p < 0.05, **p < 0.01 by one-sample t test, comparing each condition to a hypothetical value
of 0 with Sidak’s multiple comparison post hoc test. See Figure S3.
(G) MDMs derived from a D32 CCR5 homozygous donor are resistant to infection by HIV-1+ T capture. MDMs from five CCR5 WT donors or a D32 CCR5
homozygote were cocultured with heterologous HIV-1BaL-Luc
+ T cells for 6 hr, washed, and cultured for a further 3 days prior to lysis and measurement of
luciferase activity. Bars equal means of quadruplicates + SEM. *p < 0.05 Mann Whitney U. See Figure S5A.
(H and I) MDM infection by HIV-1+ T cell capture results in release of infectious virus. MDMs from four independent donors were cocultured with HIV-1BaL-Luc
+
T cells directly or across a transwell (TW) for 6 hr prior to washing and further culture ± AZT for 3 days.
(H) Supernatants from MDMs without AZT were titrated onto TZM-bl indicator cells and infectious units/ml determined.
(I) MDMs washed to remove free virus were cocultured with autologous CD4+ T cells ± AZT for 24 hr prior to collection of T cells. T cells were washed and
maintained ± AZT for 3 days prior to lysis and luciferase assay. Bars = means + SEM, *p < 0.05 by paired Students t test.
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Figure 4. HIV-1+ T-Cell-Mediated Infection
of MDMs and Viral Tropism
(A) NM-tropic HIV-1 does not establish significant
infection in MDMs. ImageStream images selected
from 5 3 104 total acquired events gated for
MDMs. HIV-1BaL supernatant virus or HIV-1BaL- or
HIV-1IIIB-infected primary T cells cocultured for
6 hr with autologous MDMs were washed free of
unattached T cells, cultured for 6 days, fixed, and
processed for ImageStream analysis. Cells were
labeled for CD3 (blue) and Gag (green), bright-
field = BF.
(B) Quantification of data from assay as in (A)
showing % MDM containing Gag and corre-
sponding supernatant p24 Gag levels after cocul-
ture with HIV-1BaL
+ T cells ± 1 hr AZT pretreatment.
Where appropriate AZT was maintained in cocul-
ture and on MDMs post-coculture for 6 days. Data
are from two independent experiments with four
independent donors, p24 analyzed in triplicate.
Bars = mean % Gag+ MDM or p24 (ng/ml) + SEM
*p < 0.05 by Mann-Whitney U comparing CTC to
AZT for each measure.
(C) Summary of data quantified from images such
as those in (A). Bars represent % Gag+ MDM +
SEM from four independent donors, separated
into CD3-associated (blue) and non-CD3-associ-
ated (red). *p < 0.05 by one-way ANOVA with
Bonferroni’s multiple comparison post hoc test comparing total %Gag+ MDM between cell-to-cell HIV-1BaL and HIV-1IIIB or HIV-1BaL cell-to cell to HIV-1BaL cell-
free. **p < 0.01 by Student’s t test comparing the proportion of CD3-associated (blue) to non-CD3-associated (red) Gag. See Figures S5B–S5D.
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infection that is greater in magnitude, at all time points and
under all conditions tested, than exposure to the cell-free viral
counterpart.
HIV-1+ T-Cell-Mediated Infection of MDM and Viral
Tropism
We hypothesized that the efficiency of MDM infection by HIV-1+
CD4+ T cell uptake might influence viral tropism, and we used
ImageStream to investigate the fate of macrophage (M)-tropic
and nonmacrophage (NM)-tropic HIV-1-infected T cells associ-
ated with MDM. We confirmed that MDM cocultured with M-
tropic HIV-1BaL
+ T cells for 6 days were productively infected:
25% of MDMs expressed cytoplasmic Gag and released free
Gag p24, and these signals were eliminated by AZT treatment
(Figure 4A and 4B). T cells infected with NM-tropic X4 virus
HIV-1IIIB were taken up by MDMs (Figure 4A), as anticipated
from the results in Figure 1A and Movie S1. However, the major-
ity of the HIV-1IIIB Gag signal within the MDM was associated
with CD3, suggesting internalized infected T cells, and the
remainder with CD3-negative vesicular compartments possibly
representing degraded T cells that had lost CD3 expression (Fig-
ures 4A and 4C). By contrast, the Gag signal inMDMs cocultured
with HIV-1BaL
+ T cells was predominantly (75%) not associated
with a CD3 signal (Figures 4A and 4C), implying infection of
15% MDMs in the absence of residual T cells or debris. How-
ever, this analysis only detects CD3 and Gag signal within the
same MDM and does not differentiate MDMs that contain a
CD3 signal with a nonassociated cytoplasmic Gag signal, which
would imply MDM infection in the presence of residual T cell ma-
terial. To probe this, we established a brightfield mask to define716 Cell Host & Microbe 16, 711–721, December 10, 2014 ª2014 Ththe MDM and then excluded CD3+ regions from this mask using
a stringent CD3 mask. This analysis revealed that for HIV-1BaL,
22% MDMs were Gag+ within which 18% contained non-
CD3-associated cytoplasmic Gag. For HIV-1IIIB 6% MDMs
were Gag+ within which4%was non-CD3-associated, a signal
not significantly above baseline (Figure S5B).
The CD3-associated HIV-1 Gag signal within MDMs might
represent a small population of viable T cells able to propagate
infection, or CD3+ debris from degraded HIV-1+ T cells. To inter-
rogate this we created a gate to report only CD3 signal repre-
senting an intact T cell, based on shape and size (round, >100
pixels in area, equivalent to 25 mm2, approximately the area of
a T cell), thereby excluding CD3+ debris (Figure S5C). We found
that2%–3% of all MDMs contained intact T cells, correspond-
ing to 6% of both HIV-1BaL and HIV-1IIIB-infected MDMs.
Furthermore, when these internalized intact T cells were
analyzed for infection, the majority (55%–70%) were Gag+ (Fig-
ure S5D). These data reveal that a small proportion of HIV-1-in-
fected MDMs contain potentially viable HIV-1+ T cells several
days postuptake but that infection of MDM, as reported by a sig-
nificant proportion of cytoplasmic Gag within MDM, only takes
place with M-tropic HIV-1.
T Cell Capture Facilitates T/F Virus Infection of MDM
Although HIV-1 transfer from infected T cells to MDMs does not
appear to expand the tropism of NM-tropic HIV-1, it may influ-
ence infection efficiency of viruses weakly tropic for MDMs.
We therefore investigated whether R5 T/F viruses that are pre-
dominantly T cell tropic by cell-free infection (Ochsenbauer
et al., 2012; Salazar-Gonzalez et al., 2009) might infect MDMs
more efficiently via HIV-1+ T cell uptake. MDMs were coculturede Authors
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Figure 5. TCell Capture Facilitates T/F Virus
Infection of MDM
(A) Primary T cells infected individually with IMCs
expressing two M-tropic R5 Envs (BaL, YU2) or 6
T/F Envs (CH040, THRO, RHPA, WITO, REJO, and
SUMA) (Ochsenbauer et al., 2012) were cultured
for 6 hr directly (CTC) or across transwells (TW)
with autologous MDMs. Following washing,
MDMs were cultured for 6 days, lysed, and lucif-
erase assayed. Results are mean signal + SEM for
each individual IMC data set pooled into M-tropic
or T/F groups from four independent donors, and
values are normalized to % Gag+ T cells prior to
coculture. **p < 0.01 Kruskal-Wallis ANOVA plus
Dunn’s multiple comparison post hoc test. See
Figure S5E.
(B) MDMswere cocultured with HIV-1+ T cells as in
(A), cultured for 10 days, and supernatant Gag
measured and normalized as above. Boxes
represent mean normalized Gag ± SEM of four
independent donor infections in two independent
experiments, each analyzed in triplicate. AUC
analysis **p < 0.01; ***p < 0.001.
(C) MDM cocultured with primary autologous
CD4+ T cells infected with the IMCs expressing
Env from HIV-1BaL, HIV-1CH040, or HIV-1THRO for
7 days were washed to remove T cells cultured for
a further 6 days; fixed; and labeled for confocal
fluorescence microscopy with anti-CD3 (green)
and Gag p17 (red) antibodies. BF = brightfield;
scale bars = 20 mm.
(D) MDMs were cocultured with T cells infected
with the IMCs shown or infectedwith concentrated
cell-free virus at the MOIs shown for 6 hr, cultured
for a further 3 days, washed, lysed, and luciferase
assayed. Results are mean signal ± SEM for four
independent donors. Left panel is cell-free (CF)
infection; right panel is cell-to-cell (CTC) infection.
(E) MDMs were cocultured with IMC-infected
T cells for 3 hr with the inhibitors shown, washed,
and cultured for a further 3 days in the continued
presence of the inhibitors. MDM, were washed,
lysed, and assayed for luciferase activity. Individ-
ual datum points = the mean of three to four
independent donors from two independent ex-
periments for each virus tested. Lines represent
the overall mean for each group (M-tropic or T/F).
*p < 0.05; ***p < 0.001 by one-sample t test
comparing means to a hypothetical value of 0 (no
inhibition) with Sidak’s multiple comparison post
hoc test.
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Macrophage Infection by HIV-Infected T Cellsdirectly, or across transwells, with CD4+ T cells infected inde-
pendently with six different T/F viruses or two chronic M-tropic
luciferase-encoding IMCs (Figure S5E) as before and assayed
for infection. Cell-free infection by M-tropic HIV-1 IMCs gave
robust luciferase signals at day 6 (Figure 5A) and Gag release
over 10 days (Figure 5B). By contrast, cell-free T/F virus MDM
infection yielded 10-fold lower levels of luciferase than HIV-
1BaL and HIV-1YU2 (Figure 5A) and insignificant Gag release
compared to baseline over 10 days (Figure 5B), consistent with
previous reports (Ochsenbauer et al., 2012; Salazar-Gonzalez
et al., 2009). However, direct coculture of T/F virus-infected
T cells with MDMs yielded 30-fold greater day 6 luciferaseCell Host &and significantly (p < 0.001) greater Gag release than cell-
free infection (Figure 5B). T/F virus infection of MDMs was
confirmed by imaging MDMs at day 6 postcoculture, demon-
strating extensive cytoplasmic Gag in the absence of intact
T cells, although residual scattered CD3+ T cell debris was
evident in some MDMs (Figure 5C). The enhanced ability of T/F
viruses to infect MDMs via cell-to-cell spread from infected
T cells might be explained by an increased multiplicity of infec-
tion (MOI) imparted by this mode of spread. To test this we
exposed MDM to increasing titers of cell-free M-tropic or T/F
IMCs and evaluated MDM infection after 3 days. M-tropic
HIV-1BaL-luc and HIV-1YU2-luc gave robust luciferase signals thatMicrobe 16, 711–721, December 10, 2014 ª2014 The Authors 717
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overlapping that obtained by capture of HIV-1+ T cells (Fig-
ure 5D). A similar range of signals was also observed for the T/
F virus REJO up to the maximum obtainable MOI of 2. Thus,
the efficiency of cell-to-cell infection is recapitulated for these
viruses by high-MOI, cell-free infection. By contrast, despite
similar input cell-free MOI maxima of 10 for WITO and 2 for
CH040, infection levels remained low, giving maximum lucif-
erase values 5- to 50-fold below that obtained by the cell-to-
cell route of MDM infection (Figure 5D). Increasing the MOI of
cell-free T/F virus inocula therefore increased MDM infection in
a virus-strain-dependent manner. Since T/F viruses display
reduced tropism for MDMs compared to chronic M-tropic vi-
ruses and may have different sensitivity to inhibitors of CD4-
and CCR5-gp120 binding (Chikere et al., 2014; Ochsenbauer
et al., 2012; Parker et al., 2013), we compared T/F virus inhibition
by the same entry inhibitors used against HIV-1Bal (Figure 3F).
MDMs were cocultured with autologous T cells infected with
the IMC panel, washed, and cultured in the continued presence
of the inhibitors for 6 days. All inhibitors strongly inhibited MDM
infection by all viruses with the exception of 2G12, which only
weakly inhibited neutralization-resistant strain HIV-1YU2 and
some T/F viruses (Figure 5E). These data confirm that MDM
infection via capture of M-tropic and T/F virus-infected T cells
is equivalently sensitive to entry inhibition.
DISCUSSION
Our results reveal a mechanism of efficient HIV-1 cell-to-cell
spread driven by MDM capture of HIV-1+ T cells. The finding
that macrophage infection may be initiated in this way has impli-
cations for infection in vivo. Macrophage recognition and uptake
of HIV-1-infected healthy and dying T cells might take place at
all times during natural infection, and both live and dead/dying
T cells are potent carriers of infectivity (Sealy et al., 2009). This
mode of viral spread could occur shortly after transmission
when T/F viruses replicate locally in Lamina Propria CD4+
T cells and later when massive infection and death of CD4+
T cells in secondary lymphoid tissues (Li et al., 2005; Mattapallil
et al., 2005) might drive substantial macrophage uptake of
HIV-1+ T cells. Conversely, the finding that NM-tropic viral Gag
may persist within T cells engulfed by macrophages may impact
upon interpretation of data from macrophages obtained ex vivo
from HIV- or SIV-infected hosts. Detection of vDNA or viral pro-
teins within phagocytes including macrophages and monocytes
may not necessarily represent their infection but may indicate
uptake of infected immune cells or their debris.
We show that HIV-1-infected T cells are captured by MDMs
using interactions apparently distinct from those mediating con-
ventional VS formation (Sattentau, 2008) but have yet to define
the uptake recognition signals. Since immunodeficiency virus-in-
fected T cells die in vitro and in vivo (Li et al., 2005; Mattapallil
et al., 2005), we explored macrophage recognition of this pro-
cess by attempting to block death receptor-ligand interactions
using published inhibitors. However, none significantly reduced
HIV-1+ T cell capture. This might reflect the highly redundant na-
ture of these interactions (Devitt and Marshall, 2011; Poon et al.,
2010), or that the receptor-ligand interactions implicated in this
process are as yet undefined, or that the pathway of macro-718 Cell Host & Microbe 16, 711–721, December 10, 2014 ª2014 Thphage recognition of dead/dying cells is distinct from that used
for HIV-1+ T cell recognition. We have not explored the cell
biology of HIV-1 infection of macrophages following capture of
infected T cells here. Uptake of HIV-1+ T cells by macrophages
leading to T cell degradation in a maturing lysosomal environ-
ment may indeed occur for a proportion of engulfed T cells.
However, it is evident from our data that some virus escapes
from infected T cells prior to degradation, leading to robust
macrophage infection. Whether this takes place during HIV-1+
T cell capture at the plasma membrane or later from within the
uptake compartment remains to be determined. Regardless of
the membrane with which virus fuses, entry via this mode of
infection is dependent on the expression of CD4 and CCR5, as
demonstrated by our inhibitor analyses. A somewhat surprising
finding was that a small percentage of engulfed T cells remained
intact within macrophages for up to 6 days and possibly longer.
Although it is unclear whether any of these cells were viable, it
appears that they were taken up into a nondegradative compart-
ment within which they persisted for extended periods.
The magnitude of MDM infection achieved by capture of
T cells infected by the M-tropic viruses and the T/F virus
REJO, which we have previously described as having a stronger
macrophage tropism than most T/F viruses (Ochsenbauer et al.,
2012), was recapitulated by a high cell-free MOI infection. Thus,
for these viruses, the efficiency of this mode of macrophage
infection is probably determined solely by quantitative aspects
of virus transfer from the infected T cell. However, even at high
MOI, two other T/F viruses (WITO and CH040) did not achieve
a level of infection equivalent to that of cell-to-cell infection, an
observation consistent with the particularly weak MDM tropism
of these viruses (Ochsenbauer et al., 2012; Salazar-Gonzalez
et al., 2009). Increasing the cell-free MOI to >10 may overcome
entry restrictions to WITO and CH040, giving an equivalent
infection to the cell-to-cell route. However, since T/F viruses
appear to have a reduced affinity for CD4 and altered interaction
with CCR5 compared to M-tropic viruses (Ochsenbauer et al.,
2012; Parker et al., 2013), a further possibility is that capture
of HIV-1-infected T cells by macrophages may drive clustering
of viral receptors at the interface, facilitating virus-receptor
engagement and entry as reported for VS formation between
HIV-1-infected and uninfected T cells (Jolly et al., 2004).
The idea that a pathogen may disseminate from one infected
cell type to another by phagocyte engulfment is not new and
has been termed a ‘‘Trojan horse’’ strategy with respect to Leish-
mania major parasite dissemination within an infected host (Rit-
ter et al., 2009). In this model, neutrophils that engulf L. major
harbor the parasites in an infectious form, ultimately dying and
passing them onto their principal host cell, the macrophage (Pe-
ters et al., 2008). Similarly, macrophages that have engulfed
Mycobacterium tuberculosis bacilli undergo apoptosis and are
subsequently phagocytosed by newly recruited macrophages,
efficiently spreading the infection (Davis and Ramakrishnan,
2009). Finally, Listeria monocytogenes-induced PS exposure
on infected cells mimics apoptotic signals that enhance cell-
to-cell spread of this bacterium to macrophages (Czuczman
et al., 2014). Our observation of the capture of HIV-1-infected
T cells by macrophages extends this phenomenon to viruses
and may have important implications for spread of viruses to
phagocytic cells within infected hosts.e Authors
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Cells and Virus
MDMwere generated and maintained as detailed in Groot et al. (2008), except
that monocytes were negatively selected from donor peripheral blood mono-
nuclear cells using monocyte isolation kit-II (Miltenyi Biotec). Autologous CD4+
T cells were negatively selected from PHA/IL-2-stimulated peripheral blood
mononuclear cells (CD4 isolation kit, Miltenyi Biotec) and infected with the
following viruses: WT HIV-1BaL or HIV-1IIIB (NIBSC Centre for AIDS Reagents,
CFAR), 5–50 ng CA-p24 per 13 107 CD4+ T cells for 7 days in complete RPMI
1640/10% fetal calf serum/10 U/ml IL-2 (CFAR). Replication-competent IMC
stably expressing Renilla reniformis luciferase in an isogenic NL4.3 backbone
(NL-LucR.T2A) encoding diverse env ectodomains in cis (Ochsenbauer et al.,
2012) were prepared by 293T transfection and titered on TZM-bl cells. Envs
were R5 M tropic (BaL, YU2), R5 T/F (RHPA, THRO, WITO, REJO, SUMA
and CH040), and X4 NL4.3 NM tropic (Ochsenbauer et al., 2012). T cells
were 10%–20% Gag+ on the day of use as determined by flow cytometry
(FACSCalibur, BD Biosciences). For live-cell imaging experiments, Jurkat-
Tat-R5 or primary CD4+ T cells were infected with the X4 HIV-1NL4.3-GFP or
mCherry IMC expressing R5 T/F Env CH077 (NL4.3-RFP (HIV-1CH077/mCherry)
by magnetofection (Sacha and Watkins, 2010) to achieve >15% GFP+ or
mCherry+ cells at 2 days postinfection.
Viral Transmission Experiments
T cell to MDM HIV-1 transmission was by direct coculture or across transwell
membranes (3.0 mm, Costar) or cell-free supernatant added directly to target
cells. Within-donor variability in T cell infection levels between IMCs in MDM
infection readouts was normalized in Figures 5A and 5B to starting T cell
infection levels. In some experiments, MDMs were incubated with AZT
(5 mM, CFAR) for up to 12 hr pre-coculture and maintained in the medium.
For qPCR assay of vDNA, total DNA was extracted with the DNeasy blood
and tissue kit (QIAGEN) and amplified using HIV-1 pol and b-globin primers
(Martin et al., 2010), and results were expressed as pol:b-globin to normalize
to cell number. For luciferase readout, cell lysates were prepared (Glo-Lysis
buffer, Promega) and 50 ml lysate mixed with 50 ml Ren-Glo luciferase solu-
tion (Promega) at RT and activity (relative light units, RLU) measured after
10 min. For GFP-reporting of MDM infection, PHA/IL-2-activated CD4+
T cells were synchronously magnetofected or mock infected for 48 hr with
HIV-1BaL-GFP. T cells were washed, added to autologous MDM 1:1, and co-
cultured for 6 hr. Following coculture, free or loosely attached T cells were
washed off with 10 mM EDTA, MDMs were cultured, and productive infection
was analyzed at day 3 post-coculture by fixing and confocal microscopy. For
VSVg-mediated HIV-1 transduction, PHA/IL-2-activated CD4+ T cells were
synchronously magnetofected for 48 hr with HIV-1BaL or VSV-G pseudo-
typed HIV-1BaLDEnv (CFAR, NIBSC) or mock infected. Infected CD4
+ T cells
were added to autologous MDM (1:1) and cocultured for 3 hr. MDMs were
washed before lifting in 5 mM EDTA/12 mM lidocaine, fixation, permeabiliza-
tion, staining, and analysis by flow cytometry. For p24 ELISA, supernatants
were removed, centrifuged, and inactivated with 0.5% empigen/56C (Groot
et al., 2008).
Inhibitors of Viral Entry, HIV-1+ T Cell Uptake, and Cellular Function
Inhibitors of MDM uptake were jasplakinolide (5 mM, Molecular Probes) and
5-N-ethyl-N-isopropyl amiloride (EIPA, 50 mM, Sigma-Aldrich). Inhibitors of
HIV-1 Env-receptor interactions were 13B.8.2, CD4-specific gp120 blocking
mAb (10 mg/ml Beckman-Coulter); soluble CD4 (20 mg/ml, IAVI); Tak-779
(500 nM, CFAR); 2G12 (10 mg/ml, IAVI); and T20 (7.5 mg/ml, CFAR). Relevant
isotype controls were used at matched concentrations. MDM Fc receptors
were blocked in 10 mg/ml pooled human IgG at 37C for 1 hr. Inhibitors were
preincubated with MDMs and/or T cells at 37C and maintained during cocul-
ture (HIV-1 Env receptor inhibitors) or washed out after preincubation with
MDMs (MDM uptake inhibitors). MDMs were pretreated with 13B8.2, T20,
Tak-779, EIPA, or jasplakinolide. HIV-1-infected T cells were pretreated with
sCD4, 2G12, or T20.
Confocal Microscopy
Performed as described previously in Groot et al. (2008). Cells were fixed in 4%
paraformaldehyde (PFA) for 1 hr, quenched with 50 mM NH4Cl in PBS forCell Host &20 min, nuclei stained with 1 mg/ml Hoechst in PBS, and cells permeabilized
in wash buffer (WB, 0.1% saponin/0.5% BSA in PBS + 5% pooled human
and goat serum). Samples were stained for CD3 (UCHT1-IgG1, BD Biosci-
ences or UCHT1-IgG2a, P. Beverley), mouse anti-HIV-1 Gag p17 (CFAR,
4C9) with anti-mouse Alexa 488/647-IgG1 or -IgG2a (Invitrogen). Alternatively,
directly conjugated mouse anti-HIV-1 Gag KC57-FITC (Beckman-Coulter) and
phalloidin-TRITC (Sigma) were used. Coverslips were mounted in ProLong-
Gold Antifade (Invitrogen) and analyzed using an Olympus FV1000. Images
were acquired with a 603 oil-immersion objective and processed in Olympus
Fluoview v2.0b.
Multispectral Flow Cytometry (ImageStream)
MDM were differentiated for 7 to 10 days. Autologous HIV-1BaL-infected
CD4+ T cells were unlabeled or labeled with anti-PS-FITC (Millipore), Live/
Dead (LD)-Red (Invitrogen). In PS prelabel experiments, cells were postla-
beled with CD3-PerCP Cy5.5 (BD Biosciences), active Caspase3-APC (BD
Biosciences), and Gag (p17, p24, and p55) KC57-PE (Beckman Coulter).
For LD experiments or experiments with no T cell prelabel, cells were labeled
with CD3-APC (BD Biosciences), Caspase3-PE (BD Biosciences), and Gag
KC57-FITC (Beckman Coulter). MDMs and T cells were cocultured (1:1) for
3 hr, washed extensively with PBS/EDTA (10 mM), and lifted with cold
PBS/EDTA (5 mM)/lidocaine (12 mM). Cells were fixed in 4% PFA and per-
meabilized. T cell phenotypes (Figures S1A–S1H) and T cell phenotypes
associated with MDMs (Figures S1I–S1N) were determined. From this popu-
lation, 103 MDMs per donor were assessed manually, and internalized T cell
phenotypes were scored. The proportions of each T cell phenotype associ-
ated with MDMs were determined using the total number of T cells counted
per 103 MDMs as the denominator. Uptake index equals proportion of T cell
population phenotypes pre-coculture/MDM-associated T cell phenotypes.
For long-term infection experiments, HIV-1BaL
+ or HIV-1IIIB
+ CD4+ T cells
(1:1) or 6 hr HIV-1BaL
+ T cell supernatants were cocultured with MDM for
6 hr prior to extensive washing. MDMs were maintained for 3 to 6 days, lifted,
fixed (as above), and stained with CD3-APC and Gag KC57-FITC. Samples
were processed using ImageStream 100 or ImageStreamX and analyzed
with IDEAS 4.0 or 5.0 software (Amnis).
Flow Cytometry
Autologous HIV-1BaL
+ CD4+ T cells were labeled with PS-FITC, LD-Red, or
unstained prior to coculture and prepared as for ImageStream. Antibodies
used were as follows: CD14-APC (BioLegend), CD14-FITC (BD Biosci-
ences), CD3-FITC, CD3-APC, KC57-FITC/PE, CD4-APC, or CCR5-FITC,
together with appropriate fluorochrome-conjugated isotype controls. Cells
were gated according to scatter and staining for CD14 (MDM) or CD3 (T
cell). Samples were collected on a FACSCalibur (BD) and analyzed with
FlowJo.
Statistical Analysis
All analyses were performed with Graphpad Prism V5 or V6, and data were
initially interrogated for normal distribution. For group-wise comparisons,
one-way ANOVA with Bonferonni post hoc test (parametric), Kruskal-Wallis
one-way ANOVA with Dunn’s post hoc test (nonparametric), or two-way
ANOVA with Bonferonni post hoc test (parametric) were used to account for
multiple comparisons. Pairwise comparisons were done with Student’s t test
or Mann-Whitney U. When comparing to a hypothetical mean, one-sampled
t tests with Sidak’s post hoc test correction were used. All tests were two-
tailed with alpha < 0.05 considered significant.
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